The United States Pharmacopeia Appeals Panel today remanded the revised USP General Chapter standards <795> for nonsterile compounding and <797> for sterile compounding to an expert committee “for further engagement on the issues raised concerning the beyond-use date provisions.” USP last year postponed the effective dates for these standards and for the new General Chapter <825> radiopharmaceuticals standard due to pending appeals. The appeals panel today denied the General Chapter <825> appeal, encouraging the appellant to submit a narrower request for revision to the expert committee. AHA had urged USP to delay the <797> standard due to implementation and compliance concerns. 

Today’s announcement will delay the effective date of the revised <797> chapter, as well as the effective date of General Chapter <800> on hazardous drug handling in health care settings. While <800> will remain informational pending final revisions to <797>, AHA advises members to contact their state boards of pharmacy regarding state-level effective dates for General Chapter <800>. AHA will update members with additional information as it becomes available.  
 

Related News Articles

Headline
A new study published in JAMA Internal Medicine is confirming the role Medicare plays in decreasing disparities in health care access and coverage in the…
Headline
By integrating behavioral health into physical care and tapping into community partnerships, hospitals and health systems can develop culturally competent…
Headline
Yale New Haven Health will receive the 2021 AHA Quest for Quality Prize this week at AHA’s annual Leadership Summit for its deep commitment to improving the…
Chairperson's File
AHA’s Institute for Diversity and Health Equity has been working for more than 25 years to advance health equity, diversity and inclusion by supporting…
Blog
There’s no turning away from the physical and emotional suffering caused by the COVID-19 pandemic. We’ve experienced every type of upheaval — in some cases…
News
Reps. Peter Welch, D-Vt., Suzan DelBene, D-Wash., Darin LaHood, R-Ill., and Brad Wenstrup, R-Ohio, yesterday reintroduced the Value in Health Care Act, AHA-…